• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管性血友病中因子VIII/血管性血友病因子的碳水化合物

Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease.

作者信息

Zimmerman T S, Voss R, Edgington T S

出版信息

J Clin Invest. 1979 Nov;64(5):1298-302. doi: 10.1172/JCI109585.

DOI:10.1172/JCI109585
PMID:315413
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC371276/
Abstract

We have examined the plasma Factor VIII/von Willebrand factor (FVIII/vWF) molecule from 16 patients with von Willebrand's disease, and have found no evidence of a significant decrease of carbohydrate content in 15 of these patients. FVIII/vWF was isolated by preparative counter immunoelectrophoresis directly from plasma using antibody to Factor VIII-related antigen, reduced in sodium dodecyl sulfate in the presence of urea, and electrophoresed in 5% polyacrylamide gels to separate the FVIII/vWF subunit from other proteins. Duplicate gels were stained by either the periodic acid-Schiff (PAS) reaction or by Coomassie Brilliant Blue G250. The ratio of Coomassie: PAS was determined by spectrophotometric scanning of the gels. Transferrin was used as an internal reference standard. The ratio for 23 normal individuals was 2.4+/-0.38 and the observed range was 1.8-3.8. 15 patients with von Willebrand's disease fell within this range. One patient independently reported as having decreased FVIII/vWF carbohydrate was also studied by this technique. A ratio of 6.8 was found, indicative of decreased, though not absent, carbohydrate. Cold insoluble globulin did not represent a significant contaminant in these analyses. 11 of the von Willebrand's disease patients with normal FVIII/vWF carbohydrate had abnormal crossed immunoelectrophoretic patterns characterized by absence of the less anodic forms of Factor VIII-related antigen. Four patients had normal patterns. These studies indicate that an absence or decrease of PAS reactive FVIII/vWF carbohydrate is not a consistent abnormality in von Willebrand's disease.

摘要

我们检测了16例血管性血友病患者的血浆因子VIII/血管性血友病因子(FVIII/vWF)分子,发现其中15例患者没有明显的碳水化合物含量降低的证据。通过制备性对流免疫电泳,使用针对因子VIII相关抗原的抗体直接从血浆中分离FVIII/vWF,在尿素存在的情况下于十二烷基硫酸钠中还原,并在5%聚丙烯酰胺凝胶中电泳,以将FVIII/vWF亚基与其他蛋白质分离。重复的凝胶用高碘酸-希夫(PAS)反应或考马斯亮蓝G250染色。考马斯亮蓝与PAS的比例通过凝胶的分光光度扫描来确定。转铁蛋白用作内部参考标准。23名正常个体的比例为2.4±0.38,观察到的范围为1.8 - 3.8。15例血管性血友病患者的比例在此范围内。对一名独立报告为FVIII/vWF碳水化合物减少的患者也采用该技术进行了研究。发现比例为6.8,表明碳水化合物减少,但并非没有。冷不溶性球蛋白在这些分析中不是显著的污染物。11例FVIII/vWF碳水化合物正常的血管性血友病患者交叉免疫电泳图谱异常,其特征是缺乏因子VIII相关抗原的阳极较弱形式。4例患者图谱正常。这些研究表明,PAS反应性FVIII/vWF碳水化合物的缺失或减少在血管性血友病中并非一致的异常表现。

相似文献

1
Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease.血管性血友病中因子VIII/血管性血友病因子的碳水化合物
J Clin Invest. 1979 Nov;64(5):1298-302. doi: 10.1172/JCI109585.
2
Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.经典(I型)和变异型(IIA型)血管性血友病亚型中VIII因子/血管性血友病因子的多聚体结构、抗原特性及血浆-血小板含量的异质性异常
J Lab Clin Med. 1983 Mar;101(3):411-25.
3
Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.血管性血友病新亚型中血小板与凝血因子VIII/血管性血友病因子之间的相互作用增强。
N Engl J Med. 1980 May 8;302(19):1047-51. doi: 10.1056/NEJM198005083021902.
4
Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.血管性血友病因子对血浆中凝血因子VIII的稳定作用。关于输血后及解离的凝血因子VIII的研究以及血管性血友病患者的研究。
J Clin Invest. 1977 Aug;60(2):390-404. doi: 10.1172/JCI108788.
5
Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.对血管性血友病中缺乏的、血小板聚集所必需的一种血浆因子进行定量测定。与凝血因子VIII促凝活性及抗原含量的关系。
J Clin Invest. 1973 Nov;52(11):2708-16. doi: 10.1172/JCI107465.
6
Von Willebrand's disease: combined qualitative and quantitative abnormalities.血管性血友病:定性和定量异常并存
N Engl J Med. 1977 May 5;296(18):1024-30. doi: 10.1056/NEJM197705052961802.
7
Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.假性血管性血友病。一种血小板内在缺陷,其表现为未修饰的人凝血因子VIII/血管性血友病因子可引起血小板聚集,且其高分子量多聚体的吸附增强。
N Engl J Med. 1982 Feb 11;306(6):326-33. doi: 10.1056/NEJM198202113060603.
8
A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.血管性血友病的一种新变体(帕多瓦I型):在所有大小的多聚体存在下,由双重结构组成的血浆血管性血友病因子寡聚体
Haematologia (Budap). 1994;26(2):97-109.
9
Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.正常因子VIII/血管性血友病因子蛋白的电泳异质性,以及血管性血友病患者的异常电泳迁移率。
J Lab Clin Med. 1976 Feb;87(2):185-94.
10
Heterogeneity of sugar composition of factor VIII/von Willebrand factor in von Willebrand's disease: analysis by crossed affinoimmunoelectrophoresis using lectin (ricinus communis agglutinin-120).血管性血友病中因子VIII/血管性血友病因子糖组成的异质性:使用凝集素(蓖麻凝集素-120)通过交叉亲和免疫电泳进行分析。
Thromb Haemost. 1983 Apr 28;49(2):87-90.

引用本文的文献

1
Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent.人去唾液酸因子VIII的特性。一种不依赖瑞斯托霉素的血小板聚集剂。
J Clin Invest. 1981 Aug;68(2):321-8. doi: 10.1172/jci110259.
2
Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation.血管性血友病因子的碳水化合物部分对于维持多聚体结构和瑞斯托霉素辅因子活性并非必需,但可保护其免受蛋白水解降解。
J Clin Invest. 1984 Dec;74(6):2049-55. doi: 10.1172/JCI111628.

本文引用的文献

1
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.在噬菌体T4头部组装过程中结构蛋白的切割
Nature. 1970 Aug 15;227(5259):680-5. doi: 10.1038/227680a0.
2
A method of trace iodination of proteins for immunologic studies.一种用于免疫学研究的蛋白质微量碘化方法。
Int Arch Allergy Appl Immunol. 1966;29(2):185-9. doi: 10.1159/000229699.
3
A high resolution PAS stain for polyacrylamide gel electrophoresis.用于聚丙烯酰胺凝胶电泳的高分辨率过碘酸雪夫染色法。
Anal Biochem. 1973 Dec;56(2):361-9. doi: 10.1016/0003-2697(73)90202-9.
4
Carbohydrate deficiency of the factor VIII/von Willebrand factor Protein in von Willebrand's disease variants.血管性血友病变异型中凝血因子VIII/血管性血友病因子蛋白的碳水化合物缺乏
Science. 1976 Apr 2;192(4234):56-9. doi: 10.1126/science.1083071.
5
Determination of the von Willebrand's disease antigen (factor VIII-related antigen) in plasma by quantitative immunoelectrophoresis.用定量免疫电泳法测定血浆中血管性血友病因子抗原(因子VIII相关抗原)
J Lab Clin Med. 1975 Jul;86(1):152-9.
6
Binding of soluble form of fibroblast surface protein, fibronectin, to collagen.成纤维细胞表面蛋白纤连蛋白的可溶性形式与胶原蛋白的结合。
Int J Cancer. 1977 Jul 15;20(1):1-5. doi: 10.1002/ijc.2910200102.
7
Heterogeneity of human factor VIII. I. Characterization of factor VIII present in the supernatant of cryoprecipitate.人凝血因子VIII的异质性。I. 冷沉淀上清液中存在的凝血因子VIII的特性
J Lab Clin Med. 1978 Jan;91(1):32-46.
8
Active release of human platelet factor VIII-related antigen by adenosine diphosphate, collagen, and thrombin.二磷酸腺苷、胶原蛋白和凝血酶对人血小板因子 VIII 相关抗原的活性释放作用。
J Clin Invest. 1978 Dec;62(6):1255-63. doi: 10.1172/JCI109246.
9
Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.凝血因子VIII/血管性血友病因子蛋白。半乳糖是血管性血友病因子活性的一个隐蔽决定因素。
J Clin Invest. 1978 Aug;62(2):496-9. doi: 10.1172/JCI109152.
10
von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease.血管性血友病因子抗原II。一种在严重血管性血友病中缺乏的新型血浆和血小板抗原。
J Clin Invest. 1978 Jun;61(6):1498-507. doi: 10.1172/JCI109070.